APPENDICURE
Innovations in the Treatment of Appendix Cancer
BLOG
Category: Resource
Resource
-
Research in photoimmunotherapy offers a promising path for patients whose tumors no longer respond to standard chemotherapy. You can read the original research here: “Inhibition of P-glycoprotein using photoimmunotherapy in peritoneal metastasis mouse model” This is way too technical for me, but I did my best to make this “patient friendly”. Everyone already knows that…
-
What Appendix Cancer Patients Need to Know… I was surprised when this showed up in my “Google Alerts” for Appendiceal Cancer this morning. I was just talking with someone who had a positive Signatera result about this very subject two weeks ago. It was a low score, but tumor DNA was detected. He went in…
-
What Real Patients Told Researchers About Their Experience Based on: Bleicher et al., Annals of Surgical Oncology (March 2026) Our community is intimately familiar with this topic, but we have a lot of new members who may not be and can benefit from this information. When patients learn they may be candidates for CRS/HIPEC surgery,…
-
A Two-Stage Surgical Approach for Extensive PMP Based on research published by Sgarbura et al., Montpellier Cancer Institute (original study) Why This Research Matters to Our Community For patients with extensive PMP, getting a complete cytoreduction in a single surgery is sometimes not possible. This study offers a look at a different path forward: a…
-
Research Spotlight | March 2026 | Appendicure Education Team If you or a loved one is living with high-grade appendiceal cancer – including high-grade signet ring cell carcinoma – your oncologist may have mentioned specific mutations found in your tumor. Two of the most relevant are KRAS and PIK3CA. A newly published laboratory study offers…